Serum Proteomics for Visceral Leishmaniasis: Promise of Postgenomics Diagnostics for Public Health in Developing Countries

Publisher： Bentham Science Publishers

E-ISSN： 1875-6913|10|4|306-313

ISSN： 1875-6921

Source： Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol.10, Iss.4, 2012-12, pp. : 306-313

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative Proteomics Analysis of SKBR3 and MCF7 Breast Cancer Cell Lines Using Two Dimensional Electrophoresis: Ready to Build Postgenomics Capacity for OMICS R&D in Developing Countries?

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 10, Iss. 2, 2012-06 ,pp. : 132-137

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of Novel Vaccine Candidates and Drug Targets Against Visceral Leishmaniasis Using Proteomics and Transcriptomics

By  

Current Drug Targets, Vol. 9, Iss. 11, 2008-11 ,pp. : 938-947

Bentham Science Publishers

Access to resources Recommend Favorite

Developments in the treatment of visceral leishmaniasis

By den Boer Margriet Leontine   Alvar Jorge   Davidson Robert N   Ritmeijer Koert   Balasegaram Manica  

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 3, 2009-09 ,pp. : 395-410

Informa Healthcare

Access to resources Recommend Favorite

Treatment of visceral leishmaniasis

By Sundar Shyam   Rai Madhukar  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. : 2821-2829

Informa Healthcare

Access to resources Recommend Favorite

Improving health in developing countries with biotechnology

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 385, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite